Venture Round - Endocyte

Venture Round - Endocyte

Investment Firm

Overview

Endocyte is a biopharmaceutical company that develops receptor-targeted therapeutics to treat cancer and inflammatory diseases.

Announced Date

Nov 13, 2006

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

6

Investor Name
Participant InvestorTwilight Venture Partners
Participant InvestorBurrill & Company
Participant InvestorBlue Chip Venture Company
Participant InvestorTriathlon Medical Venture Partners
Participant InvestorSanderling Ventures

Round Details and Background

Endocyte raised $30000000 on 2006-11-13 in Venture Round

Endocyte is a biopharmaceutical company that develops receptor-targeted therapeutics to treat cancer and inflammatory diseases.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 26, 2007
Series C - Endocyte
6-15.0M
Dec 27, 2010
Debt Financing - Endocyte
-8.1M
Aug 30, 2010
Venture Round - Endocyte
2-15.0M
Jan 19, 2010
Series C - Endocyte
6-26.0M

Recent Activity

There is no recent news or activity for this profile.